MedCity News June 26, 2024
These notes serve not only as a means to raise capital but also as a bridge to future financing rounds or significant liquidity events.
In the realm of biotech and pharmaceuticals, fundraising often plays a pivotal role in driving innovation and progress. Biotech and pharmaceutical companies, whether private startups or established public firms, frequently turn to convertible notes as a strategic financial instrument. These notes serve not only as a means to raise capital but also as a bridge to future financing rounds or significant liquidity events. Convertible notes are utilized, structured, valued, and accounted for in various ways within the context of the biotech and pharmaceutical industries.
Private companies
For burgeoning private biotech and pharmaceutical firms, navigating the journey...
Today's Sponsors
Today's Sponsor